Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 28, 2021; 27(28): 4493-4503
Published online Jul 28, 2021. doi: 10.3748/wjg.v27.i28.4493
Published online Jul 28, 2021. doi: 10.3748/wjg.v27.i28.4493
Recent advances in gastrointestinal cancers
Natacha Bordry, Christoforos Astaras, Thibaud Koessler, Department of Oncology, University Hospital of Geneva (HUG), Genève 1205, Switzerland
Marie Ongaro, Nicolas Goossens, Jean Louis Frossard, Divison of Gastroenterology and Hepatology, University Hospital of Geneva (HUG), Genève 1205, Switzerland
Author contributions: Bordry N, Astaras C and Koessler T designed the study and wrote the manuscript; Ongaro M, Goossens N and Frossard JL reviewed and corrected the manuscript; all authors have read and approved the final manuscript.
Conflict-of-interest statement: No conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Thibaud Koessler, MD PhD, Chief Doctor, Doctor, Department of Oncology, University Hospital of Geneva (HUG), rue Gabrielle Perret-Gentil 4, 1211, Genève 1205, Switzerland. thibaud.kossler@hcuge.ch
Received: January 28, 2021
Peer-review started: January 28, 2021
First decision: March 29, 2021
Revised: April 11, 2021
Accepted: July 5, 2021
Article in press: July 5, 2021
Published online: July 28, 2021
Peer-review started: January 28, 2021
First decision: March 29, 2021
Revised: April 11, 2021
Accepted: July 5, 2021
Article in press: July 5, 2021
Published online: July 28, 2021
Core Tip
Core Tip: Gastrointestinal cancers are one of the most frequent cancers and a leading cause of cancer deaths worldwide. Gastroenterologists, hepatologists and visceral surgeons interact daily with these patients. Bringing the community up to speed with new treatment paradigms in gastrointestinal oncology could improve patient care. Here we provide a clear, comprehensive and short overview of the most important practice changing trials from 2020.